Literature DB >> 11259318

Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.

Y Lin1, P Lu, C Tang, Q Mei, G Sandig, A D Rodrigues, T H Rushmore, M Shou.   

Abstract

Most cytochrome P450 (P450 or CYP)-catalyzed reactions are adequately described by classical Michaelis-Menten kinetic parameters (e.g., Km and Vmax), which are usually determined by a saturation profile of velocity of product formation versus substrate concentration. In turn, these parameters may be used to predict pharmacokinetics. However, some P450 enzymes exhibit atypical or non-Michaelis-Menten kinetics, due largely to substrate inhibition at higher concentrations of substrate. Although the mechanism of substrate inhibition is unknown, ignoring it and truncating the data can lead to erroneous estimates of kinetic parameters. In the present study, 13 P450 marker substrates were examined with 10 recombinant P450 proteins, and 6 were found, to varying degrees, to exhibit substrate inhibition. To understand the nature of the inhibition, a kinetic model was proposed (assuming that two binding sites exist on the enzyme) and used to fit the experimental data. The derived data indicated that 1) the K(I) values (substrate inhibition) were approximately 1.2- to 10-fold greater than the respective K(S) values; 2) both K(S) and K(I) values may be affected by the interaction of the two bound substrates within the enzyme, exhibited by a factor alpha (alpha = 5.1-23.3); and 3) enzyme activity was inhibited markedly (39-97%) at excess concentrations of the substrates (beta = 0.03-0.61). These findings suggest that substrates have access to both the inhibitory site and catalytic site simultaneously (K(I) > K(S)). Furthermore, the two sites, in the presence of substrate, can interact with each other. Therefore, the degree of inhibition of the enzyme is dependent on the concentration of the substrate (usually >K(I)) that sufficiently occupies the inhibitory site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259318

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  29 in total

Review 1.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

2.  Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.

Authors:  Eleanore Seibert; Timothy S Tracy
Journal:  Methods Mol Biol       Date:  2021

3.  Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probe.

Authors:  Dmitri R Davydov; Alexandra E Botchkareva; Nadezhda E Davydova; James R Halpert
Journal:  Biophys J       Date:  2005-04-15       Impact factor: 4.033

4.  Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.

Authors:  Anna L Blobaum; Thomas M Bridges; Frank W Byers; Mark L Turlington; Margrith E Mattmann; Ryan D Morrison; Claire Mackie; Hilde Lavreysen; José M Bartolomé; Gregor J Macdonald; Thomas Steckler; Carrie K Jones; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Shaun R Stauffer; J Scott Daniels
Journal:  Drug Metab Dispos       Date:  2013-09-03       Impact factor: 3.922

5.  A key cytochrome P450 hydroxylase in pradimicin biosynthesis.

Authors:  Kandy L Napan; Jia Zeng; Jon Y Takemoto; Jixun Zhan
Journal:  Bioorg Med Chem Lett       Date:  2011-10-28       Impact factor: 2.823

6.  Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2009-12-09       Impact factor: 3.922

Review 7.  Measuring specificity in multi-substrate/product systems as a tool to investigate selectivity in vivo.

Authors:  Yin-Ming Kuo; Ryan A Henry; Andrew J Andrews
Journal:  Biochim Biophys Acta       Date:  2015-08-29

8.  Direct electrochemistry of Shewanella oneidensis cytochrome c nitrite reductase: evidence of interactions across the dimeric interface.

Authors:  Evan T Judd; Matthew Youngblut; A Andrew Pacheco; Sean J Elliott
Journal:  Biochemistry       Date:  2012-12-12       Impact factor: 3.162

Review 9.  Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4.

Authors:  Stéphane Mouly; Christophe Meune; Jean-François Bergmann
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

10.  Explaining the atypical reaction profiles of heme enzymes with a novel mechanistic hypothesis and kinetic treatment.

Authors:  Kelath Murali Manoj; Arun Baburaj; Binoy Ephraim; Febin Pappachan; Pravitha Parapurathu Maviliparambathu; Umesh K Vijayan; Sivaprasad Valiyaveettil Narayanan; Kalaiselvi Periasamy; Ebi Ashley George; Lazar T Mathew
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.